FB2024_03 , released June 25, 2024
Allele: Dmel\Gripex36
Open Close
General Information
Symbol
Dmel\Gripex36
Species
D. melanogaster
Name
FlyBase ID
FBal0156419
Feature type
allele
Associated gene
Associated Insertion(s)
Carried in Construct
Also Known As
dgripex36
Key Links
Nature of the Allele
Progenitor genotype
Cytology
Description

Imprecise excision of P{GT1}BG01736 has removed the entire Grip coding region.

Mutations Mapped to the Genome
Curation Data
Type
Location
Additional Notes
References
Variant Molecular Consequences
Associated Sequence Data
DNA sequence
Protein sequence
 
Expression Data
Reporter Expression
Additional Information
Statement
Reference
 
Marker for
Reflects expression of
Reporter construct used in assay
Human Disease Associations
Disease Ontology (DO) Annotations
Models Based on Experimental Evidence ( 0 )
Disease
Evidence
References
Modifiers Based on Experimental Evidence ( 1 )
Disease
Interaction
References
Comments on Models/Modifiers Based on Experimental Evidence ( 0 )
 
Disease-implicated variant(s)
 
Phenotypic Data
Phenotypic Class
Phenotype Manifest In
Detailed Description
Statement
Reference

At stages 13-14, approximately 40% of muscles are normal in mutant embryos, approximately 50% have abnormal projections and approximately 10% are rounded. Most muscles recover as embryogenesis proceeds in the mutant embryos, such that at stage 16, more than 80% of muscles are normal, while the remainder either have abnormal projections or are rounded.

Muscle VL1 exhibits abnormal morphology in approximately 50% of cases in Gripex36 embryos, either occasionally showing a rounded morphology or, more commonly, failing to span the entire abdominal segment.

Gripex36 mutants exhibit abnormal muscle patterning.

Gripex36 mutants show defects in ventrolateral muscle (VLM) morphogenesis. Instead of forming a single polarized muscle projection, the VLMs of Gripex36 mutants frequently send out two or more projections in essentially randomized directions. When the

muscle guidance period ceases, these VLMs typically form ball-like structures that extend over only about half of a hemisegment without reaching their target tendon cell. Lateral transverse muscles (LTMs) appear unaffected.

Expression of GripΔ1-3.Scer\UAS, under the control of Scer\GAL4twi.PG leads to very strong defects in lateral transverse muscles (LTMs) Gripex36 and Gripex36/+ backgrounds. LTM defects include splitting into multiple projections, bending away from their target tendon cells and forming aberrant, integrin positive attachments in ectopic positions. These defects appear qualitatively very similar when scored in embryos or in larvae. Scer\GAL4twi.PG>GripΔ1-3.Scer\UAS expression in a Gripex36 or Gripex36/+ background results in slight ventrolateral muscle (VLM) defects.

Gripex122/Y mutant animals exhibit abnormal patterning of the ventral longitudinal muscles (VLMs). The VLMs of the mutants appear rounded instead of stretched between the attachment sites at the segment borders. Affected VLMs position themselves randomly more at either the anterior or posterior end of the segment borders. IN weaker cases, while still attached to both segment borders, the mutant VLMs appear irregularly shaped and do not align in register at the segment borders. Over 95% of all VLMs 6/7 are affected Hemizygous and Gripex122/Gripex36 animals develop into larvae which maintain the defective VLM pattern seen in embryos. Within these animals, the embryonically affected muscles grow and elongate throughout larval development. No sign of muscle degeneration is recognisable. affected VLMs produce ectopic intrasegmental attachments. These attachments form at the inner layer of muscles and not at the epidermis. Both in embryos and in larvae, even the most affected mutant VLMs form multiple extensions. Defective VLMs also have normal organisation of the contractile apparatus. Adult escapers show a shrunken abdomen and defective head posture. No other defects, in particular no signs of general impairment of cell adhesion, are observed in the animals.

External Data
Interactions
Show genetic interaction network for Enhancers & Suppressors
Phenotypic Class
Phenotype Manifest In
Enhanced by
Enhancer of
Statement
Reference
Other
Statement
Reference
Additional Comments
Genetic Interactions
Statement
Reference

Gripex36, ed1X5/+ embryos exhibit more severe VLM defects than Gripex36 embryos. In severe cases, the double mutants exhibit completely deranged somatic musculature, where muscle identification is no longer possible. Lateral transverse muscles are defective in Gripex36/Y; ed1X5/+ embryos, while these muscles appear normal in both single heterozygote.

Expression of edScer\UAS.cBa, under the control of Scer\GAL4twi.PG, in a Gripex36 background, greatly enhances the muscle defects of Gripex36 embryos; ventrolateral muscles are more severely deranged and often appear to adhere to other muscles, whereas lateral transverse muscles split.

Xenogenetic Interactions
Statement
Reference
Complementation and Rescue Data
Comments

Expression of GripΔ6-7.Scer\UAS or Gripx7.Scer\UAS under the control of Scer\GAL4twi.PG results in a partial rescue of the Gripex36 ventral longitudinal muscle (VLM) phenotype, with many VLMs appearing atypically round. The Gripx3.Scer\UAS transgene also leads to a partial rescue of this phenotype.

Images (0)
Mutant
Wild-type
Stocks (0)
Notes on Origin
Discoverer
External Crossreferences and Linkouts ( 0 )
Synonyms and Secondary IDs (4)
Reported As
Name Synonyms
Secondary FlyBase IDs
    References (8)